Prof Robert Hawkins MA MB BS PhD FRCP

Honorary Professor

Full contact details
View graph of relations

Impact

  1. Commercial Development and Patient Benefit of Adoptive Cell Therapy (ACT) for Cancer

    Fiona Thistlethwaite (Participant), Robert Hawkins (Participant), Peter Stern (Participant) & David Gilham (Participant)

    Impact: Technological impacts, Health and wellbeing, Economic, Policy